271 related articles for article (PubMed ID: 15778050)
1. Improvement of absorption enhancing effects of n-dodecyl-beta-D-maltopyranoside by its colon-specific delivery using chitosan capsules.
Fetih G; Lindberg S; Itoh K; Okada N; Fujita T; Habib F; Artersson P; Attia M; Yamamoto A
Int J Pharm; 2005 Apr; 293(1-2):127-35. PubMed ID: 15778050
[TBL] [Abstract][Full Text] [Related]
2. Excellent absorption enhancing characteristics of NO donors for improving the intestinal absorption of poorly absorbable compound compared with conventional absorption enhancers.
Fetih G; Habib F; Katsumi H; Okada N; Fujita T; Attia M; Yamamoto A
Drug Metab Pharmacokinet; 2006 Jun; 21(3):222-9. PubMed ID: 16858126
[TBL] [Abstract][Full Text] [Related]
3. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
[TBL] [Abstract][Full Text] [Related]
4. Improvement of intestinal absorption of forsythoside A in weeping forsythia extract by various absorption enhancers based on tight junctions.
Zhou W; Qin KM; Shan JJ; Ju WZ; Liu SJ; Cai BC; Di LQ
Phytomedicine; 2012 Dec; 20(1):47-58. PubMed ID: 23089157
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu(1,7)]-eel calcitonin in rats.
Fetih G; Habib F; Okada N; Fujita T; Attia M; Yamamoto A
J Control Release; 2005 Sep; 106(3):287-97. PubMed ID: 15982776
[TBL] [Abstract][Full Text] [Related]
6. Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon.
Tozaki H; Komoike J; Tada C; Maruyama T; Terabe A; Suzuki T; Yamamoto A; Muranishi S
J Pharm Sci; 1997 Sep; 86(9):1016-21. PubMed ID: 9294815
[TBL] [Abstract][Full Text] [Related]
7. Permeabilities of rebamipide via rat intestinal membranes and its colon specific delivery using chitosan capsule as a carrier.
Huang BB; Li GF; Luo JH; Duan L; Nobuaki K; Akira Y
World J Gastroenterol; 2008 Aug; 14(31):4928-37. PubMed ID: 18756602
[TBL] [Abstract][Full Text] [Related]
8. Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats.
Lin Y; Fujimori T; Kawaguchi N; Tsujimoto Y; Nishimi M; Dong Z; Katsumi H; Sakane T; Yamamoto A
J Control Release; 2011 Jan; 149(1):21-8. PubMed ID: 20184931
[TBL] [Abstract][Full Text] [Related]
9. [Oral absorption enhancers of Ophiopogon japonicas polysaccharides].
Lin X; Lu Z; Xu D; Feng Y; Shen L
Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(12):1498-502. PubMed ID: 19777832
[TBL] [Abstract][Full Text] [Related]
10. Diethyl methyl chitosan as an intestinal paracellular enhancer: ex vivo and in vivo studies.
Avadi MR; Jalali A; Sadeghi AM; Shamimi K; Bayati KH; Nahid E; Dehpour AR; Rafiee-Tehrani M
Int J Pharm; 2005 Apr; 293(1-2):83-9. PubMed ID: 15778047
[TBL] [Abstract][Full Text] [Related]
11. Enhanced therapeutic effect of LK-423 in treating experimentally induced colitis in rats when administered in colon delivery microcapsules.
Smrdel P; Cerne M; Bogataj M; Urleb U; Mrhar A
J Microencapsul; 2010; 27(7):572-82. PubMed ID: 20690794
[TBL] [Abstract][Full Text] [Related]
12. Modulation of intestinal permeability by nitric oxide donors: implications in intestinal delivery of poorly absorbable drugs.
Yamamoto A; Tatsumi H; Maruyama M; Uchiyama T; Okada N; Fujita T
J Pharmacol Exp Ther; 2001 Jan; 296(1):84-90. PubMed ID: 11123366
[TBL] [Abstract][Full Text] [Related]
13. Permeation-enhancing effects of chitosan formulations on recombinant hirudin-2 by nasal delivery in vitro and in vivo.
Zhang YJ; Ma CH; Lu WL; Zhang X; Wang XL; Sun JN; Zhang Q
Acta Pharmacol Sin; 2005 Nov; 26(11):1402-8. PubMed ID: 16225765
[TBL] [Abstract][Full Text] [Related]
14. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
[TBL] [Abstract][Full Text] [Related]
15. [Effects of the liposomes coated by chitosan and its derivatives on the gastrointestinal transit of insulin].
Wu ZH; Ping QN; Lei XM; Li JY; Cai P
Yao Xue Xue Bao; 2005 Jul; 40(7):618-22. PubMed ID: 16196267
[TBL] [Abstract][Full Text] [Related]
16. Development of an oral formulation of azetirelin, a new thyrotropin-releasing hormone (TRH) analogue, using n-lauryl-beta-D-maltopyranoside as an absorption enhancer.
Sasaki I; Tozaki H; Matsumoto K; Ito Y; Fujita T; Murakami M; Muranishi S; Yamamoto A
Biol Pharm Bull; 1999 Jun; 22(6):611-5. PubMed ID: 10408236
[TBL] [Abstract][Full Text] [Related]
17. [Absorption and distribution of 5-aminosalicylic acid from its chitosan capsule degraded by colon bacteria-released enzymes in rats].
Li GF; Chen JH; Liu LJ; Guo D; Yan Y; Xu ZY; Chen ZL
Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):431-4. PubMed ID: 12754121
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs.
Takeuchi H; Matsui Y; Sugihara H; Yamamoto H; Kawashima Y
Int J Pharm; 2005 Oct; 303(1-2):160-70. PubMed ID: 16125348
[TBL] [Abstract][Full Text] [Related]
19. Effects of absorption promoters on insulin absorption through colon-targeted delivery.
Katsuma M; Watanabe S; Kawai H; Takemura S; Sako K
Int J Pharm; 2006 Jan; 307(2):156-62. PubMed ID: 16289574
[TBL] [Abstract][Full Text] [Related]
20. Effect of permeability enhancers on paracellular permeability of acyclovir.
Ates M; Kaynak MS; Sahin S
J Pharm Pharmacol; 2016 Jun; 68(6):781-90. PubMed ID: 27061718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
